Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 15, 2022 SAM #7532
SOLICITATION NOTICE

65 -- Lonza reagents, separation medium, transfection reagents and consumables

Notice Date

7/13/2022 1:27:09 PM
 

Notice Type

Presolicitation
 

NAICS

325413 — In-Vitro Diagnostic Substance Manufacturing
 

Contracting Office

NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
 

ZIP Code

20892
 

Solicitation Number

22-010482
 

Response Due

7/23/2022 8:00:00 AM
 

Point of Contact

Malinda Dehner, Phone: 3015946320, Kerry-Ann Chisholm, Phone: 3014969351
 

E-Mail Address

DehnerM@cc.nih.gov, kerry-ann.chisholm@nih.gov
(DehnerM@cc.nih.gov, kerry-ann.chisholm@nih.gov)
 

Description

The National Institutes of Health (NIH) intends to award a fixed priced purchase order on a sole source basis to Lonza Walkersville Inc,, Walkersville, MD 21793-0127 �to procure primary human cells and cell culture reagents to perform in vitro translational research evaluating the pathogenesis of vascular remodeling in pulmonary arterial hypertension for the Critical Care Medicine Department. These specifc reagents and consumables are based on compatibility requirements with the existing experiments. Lonza Walkersville produces the media to grow the primary cells use for the departments experiments and cannot be changed to another source. Compatibility is needed to continue on-going experiments; a change in supplies may be disruptive to experiments.�The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular biology. A delay in procuring these reagents would result in harm to the government if research could not continue due to the lack of supplies. This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b)(i), Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. The total dollar value of this purchase order shall not exceed the SAT at $250,000.00. Each response should include the following Business Information: a. DUNS. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Type of Company (i.e., small business, 8(a), woman owned, hubZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM� website located at http://www.sam.gov e. Capability Statement Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Malinda Dehner, Contract Specialist, dehnerm@cc.nih.gov by the due date and time marked in this notice.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/617f66f29c234034853d0ef9d8e19825/view)
 

Place of Performance

Address: Bethesda, MD 20892, USA

Zip Code: 20892

Country: USA
 

Record

SN06387887-F 20220715/220713230108 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |